Abalos Therapeutics GmbH Employee Directory
Biotechnology ResearchNorth Rhine-westphalia, Germany11-50 Employees
Abalos Therapeutics GmbH is a Düsseldorf-based biotechnology company focused on cancer immunotherapy. It pursues an arenavirus-based approach in which viral replication within cancer cells awakens both innate and adaptive immune responses to target primary tumors and metastases. The firm is led by experienced biotech entrepreneurs and immunology specialists. In October 2024, Abalos Therapeutics appointed Gerben Moolhuizen as Chief Executive Officer. The company operates within the biotechnology research industry and aims to advance immune-oncology therapies through its arenavirus-based cancer immunotherapy program.